Insights from 2023 ASH Annual Meeting


 

ASH 2023 Insights: "Preclinical & Clinical Use of AB1, a DNMT1 Protein Depleter, to Upregulate Fetal Hemoglobin in SCD"

12 views
February 2, 2024
0 Comments
Login to view comments. Click here to Login
Benign Hematology